ARA-290
Erythropoietin-derived 11-residue research peptide studied in neuropathy and tissue-protection literature.
Erythropoietin-derived 11-residue research peptide studied in neuropathy and tissue-protection literature.
The primary literature on this compound includes Brines et al., Mol Med (2014). The references below link directly to the published record.
Every lot is synthesized in the USA, verified by HPLC, and ships with its Certificate of Analysis. It is supplied strictly for laboratory research use.
Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it is not approved by the FDA for human or veterinary use, and nothing here is a protocol or a recommendation.
Researchers also ordered
- CartalaxSynthetic peptide bioregulator studied in joint and cartilage research models.
- DihexaAngiotensin IV analog studied in synaptogenesis and HGF/c-Met receptor research.
- DSIPDelta-sleep-inducing nonapeptide studied in sleep-architecture research.
- PinealonPineal-gland-derived synthetic tripeptide studied in cognitive-aging research.